Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  Akt inhibitor GDC-0068
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
A Study of Ipatasertib (GDC-0068) in Combination With Paclitaxel as Front-line Treatment for Patients With Metastatic Triple-Negative Breast Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: GO29227, NCI-2014-01665, 2014-000469-35, NCT02162719
Start Over